Oxidative stress in COPD

M Magallón, MM Navarro-García, F Dasí - Journal of clinical medicine, 2019 - mdpi.com
Numerous studies over the years have shown that oxidative stress plays a major role in the
development of the disease. Oxidative stress involvement in COPD opens up the possibility …

Chronic obstructive pulmonary disease and cerebrovascular diseases: functional and clinical aspect of comorbidity

BI Geltser, IG Kurpatov, VN Kotelnikov… - Terapevticheskii arkhiv, 2018 - ter-arkhiv.ru
Literature data of chronic obstructive pulmonary disease (COPD) and cerebrovascular
diseases (CVD) comorbidity are represented in this review. Key aspects of this interaction …

Apocynin prevents cigarette smoking‐induced loss of skeletal muscle mass and function in mice by preserving proteostatic signalling

SMH Chan, I Bernardo, C Mastronardo… - British Journal of …, 2021 - Wiley Online Library
Background and Purpose Skeletal muscle dysfunction is a major comorbidity of chronic
obstructive pulmonary disease (COPD). This type of muscle dysfunction may be a direct …

Losartan does not inhibit cigarette smoke-induced lung inflammation in mice

ML Hepworth, SL Passey, HJ Seow, R Vlahos - Scientific Reports, 2019 - nature.com
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease
largely caused by cigarette smoking (CS) and is characterized by lung inflammation and …

Risk of Cardiovascular Events Associated with Chronic Obstructive Pulmonary Disease and/or Metabolic Syndrome: A Large-Scale Nationwide Population-Based …

E Noh, H Jeong, IS Cho, MS Chang, I Yu… - … Journal of Chronic …, 2024 - Taylor & Francis
Purpose Chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
are among the most prevalent conditions that might predispose individuals to life …

Хроническая обструктивная болезнь легких и цереброваскулярные заболевания: структурно-функциональные и клинические аспекты коморбидности

БИ Гельцер, ИГ Курпатов, ВН Котельников… - Терапевтический …, 2018 - cyberleninka.ru
В обзоре представлены данные литературы по проблеме коморбидности хронической
обструктивной болезни легких (ХОБЛ) и цереброваскулярных заболеваний (ЦВЗ) …

Glycated hemoglobin (HbA1c) as a predictor of outcomes during acute exacerbations of chronic obstructive pulmonary disease

E Papathanassiou, AI Papaioannou… - COPD: Journal of …, 2021 - Taylor & Francis
Systemic inflammation may be the common denominator between COPD and type 2
diabetes and may explain the correlation in both diseases' development and progress. The …

[HTML][HTML] Cellular and Molecular Biology of Mitochondria in Chronic Obstructive Pulmonary Disease

CL Li, SF Liu - International Journal of Molecular Sciences, 2024 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder
characterized by enduring airflow limitation and chronic inflammation. Growing evidence …

[HTML][HTML] Changes in targeted metabolomics in lung tissue of chronic obstructive pulmonary disease

Y Feng, M Xie, Q Liu, J Weng, L Wei… - Journal of Thoracic …, 2023 - ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) is a common chronic lung
disease and its incidence is steadily increasing. COPD patients and mouse models of COPD …

Astaxanthin suppresses cigarette smoke and lipopolysaccharide-induced airway inflammation through induction of heme oxygenase-1

L Nian, Z Weidong, L Shujuan, C Jun… - Cellular and Molecular …, 2019 - cellmolbiol.org
The present study was carried out to evolve an effective treatment strategy for chronic
obstructive pulmonary disease (COPD). Astaxanthin (AS) is abundantly present in red …